The review process for clinical research involving investigational medicinal products

As in all EU member states, the Netherlands uses a dual review process for clinical research involving investigational medicinal products, that is, the research file must be submitted to both a reviewing committee and the Competent Authority. This process is regulated in the European Clinical Trial Directive 2001/20/EC.